Metabolic Biofouling of Glucose Sensors in Vivo: Role of Tissue Microhemorrhages

Objective: Based on our in vitro study that demonstrated the adverse effects of blood clots on glucose sensor function, we hypothesized that in vivo local tissue hemorrhages, induced as a consequence of sensor implantation or sensor movement post-implantation, are responsible for unreliable readings or an unexplained loss of functionality shortly after implantation. Research Design and Methods: To investigate this issue, we utilized real-time continuous monitoring of blood glucose levels in a mouse model. Direct injection of blood at the tissue site of sensor implantation was utilized to mimic sensor-induced local tissue hemorrhages. Results: It was found that blood injections, proximal to the sensor, consistently caused lowered sensor glucose readings, designated temporary signal reduction, in vivo in our mouse model, while injections of plasma or saline did not have this effect. Conclusion: These results support our hypothesis that tissue hemorrhage and resulting blood clots near the sensor can result in lowered local blood glucose concentrations due to metabolism of glucose by the clot. The lowered local blood glucose concentration led to low glucose readings from the still functioning sensor that did not reflect the systemic glucose level.

[1]  Bruce A Buckingham,et al.  Accuracy of the modified Continuous Glucose Monitoring System (CGMS) sensor in an outpatient setting: results from a diabetes research in children network (DirecNet) study. , 2005, Diabetes technology & therapeutics.

[2]  D. Dorsky,et al.  Enhancement of implantable glucose sensor function in vivo using gene transfer-induced neovascularization. , 2005, Biomaterials.

[3]  Ben Feldman,et al.  Importance of Interleukin-1 and Interleukin-1 Receptor Antagonist in Short-Term Glucose Sensor Function in Vivo , 2010, Journal of diabetes science and technology.

[4]  J. Dudenhausen,et al.  Introductory experience with the continuous glucose monitoring system (CGMS; Medtronic Minimed) in detecting hyperglycemia by comparing the self-monitoring of blood glucose (SMBG) in non-pregnant women and in pregnant women with impaired glucose tolerance and gestational diabetes. , 2004, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[5]  A. J. Smith,et al.  Saphenous vein puncture for blood sampling of the mouse, rat, hamster, gerbil, guineapig, ferret and mink , 1998, Laboratory animals.

[6]  Ronald Brazg,et al.  A continuous glucose sensor based on wired enzyme technology -- results from a 3-day trial in patients with type 1 diabetes. , 2003, Diabetes technology & therapeutics.

[7]  G. S. Wilson,et al.  Protein interactions with subcutaneously implanted biosensors. , 2006, Biomaterials.

[8]  Manjot Kaur,et al.  Critical role of tissue mast cells in controlling long-term glucose sensor function in vivo. , 2010, Biomaterials.

[9]  Alberto Maran,et al.  Continuous subcutaneous glucose monitoring in diabetic patients: a multicenter analysis. , 2002, Diabetes care.

[10]  Ben Feldman,et al.  Blood-Induced Interference of Glucose Sensor Function in Vitro: Implications for in Vivo Sensor Function , 2007, Journal of diabetes science and technology.

[11]  Lutz Heinemann,et al.  Continuous glucose monitoring: reliable measurements for up to 4 days with the SCGM1 system. , 2003, Diabetes technology & therapeutics.

[12]  Accuracy of the continuous glucose monitoring system in inpatient and outpatient conditions. , 2003, Diabetes & metabolism.

[13]  Manjot Kaur,et al.  Continuous glucose monitoring in normal mice and mice with prediabetes and diabetes. , 2006, Diabetes technology & therapeutics.

[14]  Ward Wk,et al.  Assessment of chronically implanted subcutaneous glucose sensors in dogs : The effect of surrounding fluid masses , 1999 .

[15]  J. Jansen,et al.  Influence of inflammatory cells and serum on the performance of implantable glucose sensors. , 2001, Journal of biomedical materials research.

[16]  W K Ward,et al.  Assessment of chronically implanted subcutaneous glucose sensors in dogs: the effect of surrounding fluid masses. , 1999, ASAIO journal.